Calcium antagonists: Stroke therapy coming of age

Stroke

Volumn 21, Issue 3, 1990, Pages 494-501

  Wong, Melvin C W ^a   Garke Haley, E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Calcium channel blockers; Cerebral vascular disorders; Drug therapy

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

BIOAVAILABILITY; CARDIOTOXICITY; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOPHLEBITIS;

BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; HUMAN; INTRACRANIAL ANEURYSM; MOLECULAR BIOLOGY; SUBARACHNOID HEMORRHAGE;

EID: 0025318130     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.21.3.494     Document Type: Article

References (68)

1. Vanhoutte PM, Paoletti R: The WHO classification of calcium antagonists. Trends Pharmacol Sci 1987; 8: 4-5
2. Miller RJ: Calcium signalling in neurons. Trends Newosci 1988; 11: 415-419
3. Marin J: Vascular effects of calcium antagonists: Uses in some cerebrovascular disorders. Gen Pharmacol 1988; 19: 295-306
4. 2+ channel explain discrepancies, Trends Pharmacol Sci 1987; 8: 115-117
5. Murphy KMM, Gould RJ, Largenl BL, Snyder SH: A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci USA 1983; 80: 860-864
6. 2+ channel? Trends Neurosci 1989; 12: 128-129
7. Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S: Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987; 328: 313-318
8. Oelmers HJ: Review: Nimodipine in ischemic stroke. Clin Neuropharmacol 1987; 10: 412-422
9. Takenaka T, Handa J: Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys, and human patients. Int J Clin Pharmacol Biapharm 1979; 17: 1-11
10. Collins RC, Dobkin BH, Choi DW: Selective vulnerability of the brain: New insights into the pathophysiology of stroke. Ann Intern Med 1989; 110: 992-1000
11. Kieswetter H, Jung F, Radtke H, Roggenkamp G, Schneider R: Investigation of the Theological effectiveness of nimodipine in comparison to other established rheologica with an in vitro stress model of calcium, in Betz E, Deck K, Hoffmeister F (eds): Nimodipine. Pharmacological and Clinical Properties. Stuttgart, Schattauer Verlag, 1985, pp 127-135
12. Schachter M: Do calcium antagonists affect platelets? Eur Heart J 1987; 8: 75-82
13. Mehta JL: Influence of calcium-channel blockers on platelet function and arachidonic arid metabolism. Am J Cardiol 1985; 55: 158B-164B
14. Parmley WW, Blumlein S, Sievers R: Modification of experimental atherosclerosis by calcium-channel blockers. Am J Cardiol 1985; 55: 165B-171B
15. Graham DJM, Dow RJ, Freedman D, Mroszczak E, Ling T: Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgrad Med J 1984; 60: 7-10
16. Langley MS, Sorkin EM: Nimodipine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease. Drugs 1989; 37: 669-699
17. Gengo FM, Fagan SC, Krol G, Bernhard H: Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls. Br J Clin Pharmacol 1987; 23: 47-53
18. Kirch W, Ramsch KD, Duhrsen U, Ohnhaus EE: Clinical pharmacokinetics of nimodipine in normal and impaired renal function. Int J Clin Pharmacol Res 1984; 4: 381-384
19. Capewell S: Reduced felodipine bioavailability in patients taking anticonvulsants. Lancet 1988; 2: 480-482
20. Torrealba G, Sharp A, Soto B: Nimodipine-treated subarachnoid hemorrhage associated with acute pseudo-obstruction of the colon. Surg Neurol 1987; 28: 150-152
21. Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJ: A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988; 318: 203-207
22. Gelmers HJ: The effects of nimodipine on the clinical course of patients with acute ischemic stroke. Acta Neurol Scand 1984; 69: 232-239
23. Kazda S, Towart R: Nimodipine: A new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir (Wien) 1982; 63: 259-265
24. Allen GS: Role of calcium antagonists in cerebral arterial spasm. Am J Cardiol 1985; 55: 149B-153B
25. Fujiwara S, Kuriyama H: Nicardipine actions on smooth muscle cells and neuromuscular transmission in the guinea-pig basilar artery. J Pharmacol Exp Ther 1983; 225: 447-455
26. Towart R, Perzbom E: Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteries. Eur J Pharmacol 1981; 69: 213-215
27. Zabramski J, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of calcium antagonists. Neurosurgery 1986; 18: 129-135
28. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys; Part I. Clinical and radiological findings. J Neurosurg 1984; 60: 1167-1175
29. Nosko M, Weir B, Krueger C, Cook D, Norris S, Overton T, Boisvert D: Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 1985; 16: 129-136
30. Haws CW, Heistad DD: Effects of nimodipine on cerebral vasoconstrictor responses. Am J Physiol 1984; 247: H170-H176
31. Auer LM: Preventive nimodipine and acute aneurysm surgery: Heading for the control of complications after aneurysmal subarachnoid hemorrhage. Neurochirurgia (Stuttg) 1985; 28: 87-92
32. Kucharczyk J, Chew W, Derugin N, Moseley M, Rollin C, Berry I, Norman D: Nicardipine reduces ischemic brain injury: Magnetic resonance imaging/spcctroscopy study in cats. Stroke 1989; 20: 268-274
33. Hadani M, Young W, Flamm ES: Nicardipine reduces calcium accumulation and electrolyte derangements in regional cerebral ischemia in rats. Stroke 1988; 19: 1125-1132
34. Berger L, Hakim AM: Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats. J Cereb Blood Flow Metab 1989; 9: 58-64
35. Heffez DS, Passonneau JV: Effect of nimodipine on cerebral metabolism during ischemia and recirculation in the Mongolian gerbil. J Cereb Blood Flow Metab 1985; 5: 523-528
36. Gotoh O, Mohamed AA, McCulloch J, Graham DI, Harper AM, Teasdale GM: Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1986; 6: 321-331
37. Germano IM, Bartkowski HM, Cassel ME, Pitts LH: The therapeutic value of nimodipine in experimental focal cerebral ischaemia. J Neurosurg 1987; 67: 81-87
38. Marcoux FW: Calcium channel antagonists in the treatment of experimental stroke (abstract). Stroke 1986; 17: 145
39. Sauter A, Rudin M: Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke 1986; 17: 1228-1234
40. Kazda S, Hoffmeister F, Garthoff B, Towart R: Prevention of the post ischemic impaired reperfusion of the brain by nimodipine (Bay e 9736). Acta Neurol Scand 1979; 60 (suppl 72): 302-303
41. Hoffmeister F, Kazda S, Krause HP: Influence of nimodipine (Bay e 9736) on the postischaemic changes of brain function. Acta Neurol Scand 1979; 60 (suppl 72): 358-359
42. Grotta J, Spydell J, Pettigrew C, Ostruw P, Hunter D: The effect of nicardipine on neuronal function following ischemia. Stroke 1986; 17: 213-219
43. Lazarewicz JW, Pinta R, Salinska E, Puka M: Beneficial effect of nimodipine on metabolic and functional disturbances in rabbit hippocampus following complete cerebral ischemia. Stroke 1989; 20: 70-77
44. Steen PA, Newberg LA, Milde JH, Michenfelder JD: Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1984; 4: 82-87
45. Steen PA, Gisvold SE, Milde JH, Newberg LA, Scheithauer BW, Lanier WL, Michenfelder JD: Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 1985; 62: 406-414
46. Kassell NF, Sasaki T, Colohan ART, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562-572
47. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK. Strom JA, Transou CR: Cerebral arterial spasm - A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619-624
48. Philippen J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P: Prevention of vasospasm in subarachnoid hemorrhage: A controlled study with nimodipine. Acta Neurochir (Wien) 1986; 82: 110-114
49. Neil-Dwyer G, Mce E, Dorranoe D, Lowe D: Early intervention with nimodipine in subarachnoid hemorrhage, Eur Heart J 1987; 8K: 41-47
50. Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter M, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A: Nimodipine treatment in poor-grade aneurysm patients: Results of a multicenter double-blind placebo-controlled trial, J Neurosurg 1988; 68: 505-517
51. Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J 1989; 298: 636-642
52. Auer LM, Oberbauer RW, Schalk HV: Human pial vascular reactions to intravenous niraodipine-infusion during EC-IC bypass surgery. Stroke 1983; 14: 210-213
53. Auer LM, Suzuki A, Ito Z: Intraoperative topical nimodipine after aneurysmal clipping. Neurochirurgia (Stuttg) 1984; 27: 36-38
54. Auer LM: Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. Neurosurgery 1984; 15: 57-66
55. Auer LM, Brandt L, Ebeling U, Gilsbach J, Groeger U, Harders A, Ljunggren B, Oppel F, Rewen HJ, Saeveland H: Nimodipine and early aneurysm operation in good condition SAH patients. Acta Neurochir (Wien) 1986; 82: 7-13
56. Ljunggren B, Brandt L, Saveland H, Nilsson PE, Cronqvist S, Andersson KE, Vinge E: Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg 1984; 61: 864-873
57. Kazda S: Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity. Neurochirurgia (Stuttg) 1985; 28: 70-73
58. Koos WT, Pemeczky A, Auer LM, Böker DK, Gaab M, Jaksche H, Kostron H, Meinig G, Muizelaar JP, van der Werf AJM, Seibert HK, Ulrich F, Sprung CH: Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Neurochirurgia (Stuttg) 1985; 28: 114-117
59. Saveland H, Ljunggren B, Brandt L, Messeter K: Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine. Neurosurgery 1986; 18: 146-150
60. Gilsbach JM, Harders AG: Morbidity and mortality after aneurysm surgery - Prospective study with nimodipine prevention. Acta Neurochir (Wien) 1989; 96: 1-7
61. Seiler RW, Reulen HJ, Huber P, Grolimund P, Ebeling U, Steiger HJ: Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: A prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound. Neurosurgery 1988; 23: 598-604
62. Jan M, Buchheit F, Tremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 1988; 23: 154-157
63. Ohman J, Heiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1988; 69: 683-686
64. Flamm ES, Adams HP Jr, Beck DW, Pinto RS, Marler JR, Walker MD, Godersky JC, Loftus CM, Biller J, Boarini DJ, O’Dell C, Banwart K, Kongable G: Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988; 68: 393-400
65. Haley EC, Tomer JC, Kassell NF, Vemberg KK, Kongable GL, Jane JA: Design of a clinical trial to evaluate vasospasm treatment, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 503-507
66. Solomon RA, Fink ME: Current strategies for the management of aneurysmal subarachnoid hemorrhage. Arch Neurol 1987; 44: 769-774
67. Oczkowski WJ, Hachinski VC, Bogousslavsky J, Bamett HJM, Carruthers SG: A double-blind, randomized trial of PY108-068 in acute ischemic cerebral infarction. Stroke 1989; 20: 604-608
68. Rosenbaum DM, et al: A pilot study of nicardipine for acute ischemic stroke. Angiology (in press)